Cite
A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease.
MLA
Harold, Denise, et al. “A Single Nucleotide Polymorphism in CHAT Influences Response to Acetylcholinesterase Inhibitors in Alzheimer’s Disease.” Pharmacogenetics, vol. 16, no. 2, Feb. 2006, pp. 75–77. EBSCOhost, https://doi.org/10.1097/01.fpc.0000189799.88596.04.
APA
Harold, D., Macgregor, S., Patterson, C. E., Hollingworth, P., Moore, P., Owen, M. J., Williams, J., O’donovan, M., Passmore, P., Mcilroy, S., & Jones, L. (2006). A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer’s disease. Pharmacogenetics, 16(2), 75–77. https://doi.org/10.1097/01.fpc.0000189799.88596.04
Chicago
Harold, Denise, Stuart Macgregor, Cathryn E. Patterson, Paul Hollingworth, Pamela Moore, Michael J. Owen, Julie Williams, et al. 2006. “A Single Nucleotide Polymorphism in CHAT Influences Response to Acetylcholinesterase Inhibitors in Alzheimer’s Disease.” Pharmacogenetics 16 (2): 75–77. doi:10.1097/01.fpc.0000189799.88596.04.